SUMMARY An attempt was made to examine the pathophysiology of the rheumatoid nodule. Significant amounts of interleukin 1-like activity and prostaglandin E2 were detected in the supernatants from in vitro organ cultures of rheumatoid nodule tissue. When fresh (but not old) rheumatoid nodules were minced and cultured in vitro prominent outgrowths of cells were observed. These cells expressed both HLA-DR and CD14 antigens but lacked conventional differentiation antigens for T cells and B cells, suggesting that they are of monocyte-macrophage origin. These data suggest that interleukin 1 and prostaglandin E2 may be deeply involved in the formation of rheumatoid nodules.
dins and collagenase from synovial cells.9 Our examination of biopsied rheumatoid synovium indicated that interleukin 1 might be strongly involved in joint destruction in rheumatoid arthritis. 10 We therefore studied the production of cytokines and prostaglandin E2 by rheumatoid nodules in an attempt to clarify the pathogenesis of these nodules.
Patients and methods
Nine patients (two men, seven women) with classical rheumatoid arthritis as defined by the American Rheumatism Association criteria1 were included in the study (Table 1 ). The duration of disease varied from eight months to 12 years, and nodules were present from two weeks to one year. All subjects except patient 7 were seropositive for rheumatoid factors, with titres ranging from 1/160 to 1/5120 on the haemagglutination test using sheep red blood cells sensitised with rabbit IgG (RAHA test). One patient was treated with 5 mg/day of prednisolone and one with 100 mg/day of D-penicillamine; the others received only non-steroidal anti-inflammatory drugs.
PREPARATION OF SAMPLES
Subcutaneous nodules were removed without complication from the olecranon region while patients were under local anaesthesia. The nodules were 220 
nodule tissue were added to concanavalin A stimulated thymocyte cultures at dilutions of 1:1 to 1:4 there was a significant reduction in thymidine incorporation compared with cultures that had higher dilutions (1:8 or higher) of the same supernatants (data not shown). This suggested that inhibitory factor(s), including prostaglandins, might be contained in the supernatants from cultured rheumatoid nodule tissue. We therefore used supernatants with dilutions higher than 1:8 to test for interleukin 1 like activity.
Supernatants from cultured rheumatoid nodule tissue harvested on day 1 of culture induced significant proliferation of thymocytes stimulated with a suboptimal dose of concanavalin A (5.0 (1-2) U/ml, mean (SE)) ( Table 2 ). This activity was greater on day 1 of culture than on days 4 or 7 (Fig. 1 ). In addition, there was a tendency for this activity to be more pronounced in 'fresh' nodules-that is, 6-4 (1-0) U/ml from fresh nodules (duration <8 weeks) v 4-0 (1.0) U/ml from 'old' nodules (duration >3 months) (p<001). Interleukin 1 activity was confirmed by growth inhibition assay using the melanoma cell line A375. Thus supernatants from day 1 of culture of rheumatoid nodule tissue significantly inhibited proliferation of the melanoma cell line (13.8 (2.5) U/ml, mean (SE)). Furthermore, the interleukin 1-like activity in the supernatants was not blocked by anti-interleukin la antibody. It was significantly inhibited by anti-interleukin 113 antibody (up to 75%), but not by normal rabbit IgG, indicating that most of the interleukin 1-like activity could be ascribed to the interleukin 13 molecule (Fig. 2) . By contrast, neither interleukin 2 nor interleukin 3 activity was detected in the supernatants from any of the culture samples tested.
PROSTAGLANDIN E2 IN SUPERNATANTS FROM CULTURED RHEUMATOID NODULE TISSUE
Supernatants from cultured rheumatoid nodule tissue contained considerable amounts of prostaglandin E2 (3650 (SE 1524) pg/ml), suggesting that prostaglandin E2 is spontaneously produced in rheumatoid nodules. There was no correlation between the amount of prostaglandin E2 in the supernatants and interleukin 1 activity, and duration of rheumatoid nodules.
SURFACE ANTIGENS OF CELLS OUTGROWN FROM RHEUMATOID NODULES
When fresh rheumatoid nodules were minced and pieces of these tissues were cultured, round mononuclear cells appeared around the tissues forming colonies (Fig. 3) . These cells were relatively large in size and had small round nuclei with large cytoplasms.
We therefore examined their surface antigens using indirect immunostaining. Results showed that these cells strongly expressed HLA-DR antigens (Fig.  4) . They also bore CD14 antigens on their surfaces. None of the T cell or B cell differentiation antigens so far tested was demonstrated, however. CD11b (Mol) antigens were weakly detected. These results suggest that these cells may belong to the macrophage lineage (Table 3) 
Cells were stained by various monoclonal antibodies as described in the 'Patients and methods' section.
RESPONSIVENESS OF CELLS OUTGROWN FROM RHEUMATOID NODULES IN VITRO
We next studied the responsiveness of these cells to various stimuli in a proliferation assay. These cells did not synthesise DNA in vitro by responding to any of the stimuli tested: phytohaemagglutinin, concancavalin A, S aureus Cowan I, and interleukin 2 (data not shown). Further, they did not spontaneously incorporate tritiated thymidine. These data indicate that these cells may not be lymphocytic in origin.
PRODUCTION OF INTERLEUKIN 1-LIKE FACTOR BY CELLS IN VITRO
When these cells were collected and cultured in vitro (5 x 105 cells/well) they spontaneously elaborated an interleukin 1-like factor. Thus supematants from these cultured cells supported a proliferation of concanavalin A stimulated thymocytes (5.0 (1.2) U/ml) and inhibited growth of the A375 melanoma cell line (10.0 (2-6) U/ml). This activity peaked on day 1 of culture and gradually declined on subsequent days. This interleukin 1-like activity was also neutralised by anti-interleukin 1,B antibody (data not shown). No other cytokine activity, including that of interleukin 2 and interleukin 3, was detected in these supematants.
REARRANGEMENT OF T CELL RECEPTOR 1 CHAIN GENE DNA from circulating granulocytes was used as non-T cells to define the normal germ-line arrangement of the T cell receptor 13 chain gene. When DNA from cells outgrown from a rheumatoid nodule was studied it manifested T cell 13 genes in the germ-line configuration. No rearranged band was observed (data not shown). These data suggosted that the cells obtained from rheumatoid nodules were not of T cell origin.
Discussion
Subcutaneous rheumatoid nodules are one of the extra-articular symptoms seen in rheumatoid arthritis. They are frequently found on pressure points at group.bmj.com on June 21, 2017 -Published by http://ard.bmj.com/ Downloaded from bony prominences and are associated with seropositivity in patients with rheumatoid arthritis. The pathogenesis of rheumatoid nodules remains to be elucidated, however.
We found both interleukin 1 like activity and prostaglandin E2 in supernatants from cultured rheumatoid nodule tissue. Interleukin 1 like activity was confirmed by both thymocyte proliferation assay and growth inhibition assay using a melanoma cell line. This activity was significantly inhibited by antihuman interleukin 1 antibodies, especially by the antibody to recombinant interleukin 1l3. Cells producing interleukin 1 activity in the nodules seem to be monocytic in origin. They responded neither to T cell nor to B cell mitogens and expressed CD14 and HLA-DR antigens on their surfaces. In addition, these cells showed the germ-line configuration of a T cell receptor gene, indicating that This, together with our present data, indicates that interleukin 1 and prostaglandin E2 may be strongly involved in both the pathogenesis of synovitis and the formation of rheumatoid nodules in rheumatoid arthritis. This study is the first to look at the production of cytokines by rheumatoid nodules in an attempt to shed light on their pathogenesis. We are currently studying the cascades or networks of cytokine production in both rheumatoid nodules and rheumatoid synovium. 
